Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrasentan and Zometa for Men With Androgen Independent Prostate Cancer Metastatic to Bone
NCT00181558Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2001
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atrasentan in prostate cancer (PCa), sponsored by Massachusetts General Hospital. Started Dec 2001; status: completed.
02
Drugs
atrasentan
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00181558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181558.